Aspira Women’s Health Inc (AWH) concluded trading on Wednesday at a closing price of $0.08, with 3.86 million shares of worth about $0.31 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -89.46% during that period and on April 16, 2025 the price saw a loss of about -12.49%. Currently the company’s common shares owned by public are about 29.78M shares, out of which, 21.30M shares are available for trading.
Stock saw a price change of -15.90% in past 5 days and over the past one month there was a price change of -29.97%. Year-to-date (YTD), AWH shares are showing a performance of -88.37% which decreased to -97.58% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.08 but also hit the highest price of $3.63 during that period. The average intraday trading volume for Aspira Women’s Health Inc shares is 4.55 million. The stock is currently trading -14.83% below its 20-day simple moving average (SMA20), while that difference is down -51.49% for SMA50 and it goes to -88.54% lower than SMA200.
Aspira Women’s Health Inc (NASDAQ: AWH) currently have 29.78M outstanding shares and institutions hold larger chunk of about 4.89% of that.
The stock has a current market capitalization of $2.44M and its 3Y-monthly beta is at 1.37. It has posted earnings per share of -$0.99 in the same period. It has Quick Ratio of 0.71. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AWH, volatility over the week remained 14.15% while standing at 14.40% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on January 12, 2022 offering an Overweight rating for the stock and assigned a target price of $4 to it. Coverage by Truist stated Aspira Women’s Health Inc (AWH) stock as a Buy in their note to investors on March 29, 2021, suggesting a price target of $12 for the stock.
